Long-term results from the phase 2 OVARIO trial (NCT03326193) highlight the effectiveness of niraparib plus bevacizumab as maintenance therapy in patients with advanced ovarian cancer.

Early fallopian tube cell changes were found in a high‑risk patient. A live tissue bank and organoid system will help explore ...

Hormonal imbalances are no longer rare or limited to a certain age group, they are a growing concern for Indian women across ...

Polycystic ovary syndrome is so fundamentally misunderstood, patients, researchers and medical professionals the world over are trying to change its name, with the effort led by Australian medical ...

My weight has fluctuated since I was a teenager. So has my mental health. When I look back at my younger years, I wonder at ...

TV star Nick Knowles and Katie Dadzie tied-the-knot in a ceremony in Essex on 7 June - and now Katie has revealed she has ...

Maya Ortiz of North Reading is organizing “Trotting In Teal,” an awareness/fundraising event for ovarian cancer that will be ...

The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

A new study published in the journal Diabetes, Obesity and Metabolism has found that cannabidiol (CBD) significantly improves metabolic health and reduces inflammation and liver fibrosis in a mouse ...

A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a ...

Genetic testing revealed that she was positive for BRCA1, a genetic mutation that increases one’s risk of breast and ovarian ...